Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials - Université de Versailles Saint-Quentin-en-Yvelines Accéder directement au contenu
Article Dans Une Revue Journal of Rheumatology Année : 2019

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials

Kathleen Andersen
Jonathan T.L. Cheah
Lyn March
Susan Bartlett
Dorcas Beaton
Clifton Bingham
Peter Brooks
Robin Christensen
Philip Conaghan
Maarten de Wit
Amylou Dueck
Susan Goodman
Shawna Grosskleg
Catherine Hill
Martin Howell
Sarah Mackie
Bethan Richards
Beverly Shea
Jasvinder Singh
Vibeke Strand
Peter Tugwell
George Wells
Lee Simon

Résumé

Objective. Outcome Measures in Rheumatology (OMERACT) convened a premeeting in 2018 to bring together patients, regulators, researchers, clinicians, and consumers to build upon previous OMERACT drug safety work, with patients fully engaged throughout all phases. Methods. Day 1 included a brief introduction to the history of OMERACT and methodology, and an overview of current efforts within and outside OMERACT to identify patient-reported medication safety concerns. On Day 2, two working groups presented results; after each, breakout groups were assembled to discuss findings. Results. Five themes pertaining to drug safety measurement emerged. Conclusion. Current approaches have failed to include data from the patient’s perspective. A better understanding of how individuals with rheumatic diseases view potential benefits and harms of therapies is essential.

Dates et versions

hal-04535512 , version 1 (06-04-2024)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

Kathleen Andersen, Jonathan T.L. Cheah, Lyn March, Susan Bartlett, Dorcas Beaton, et al.. Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials. Journal of Rheumatology, 2019, 46 (8), pp.1053-1058. ⟨10.3899/jrheum.181123⟩. ⟨hal-04535512⟩
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More